Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome

Neurology

Volumn 51, Issue 1, 1998, Pages 188-195

  Eisensehr, Ilonka ^c   Ehrenberg, B L ^a   Noachtar, S ^d   Korbett, K ^a   Byrne, A ^b   McAuley, A ^b   Palabrica, T ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN;

ADRENALIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CORONARY RISK; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SLEEP APNEA SYNDROME; THROMBOCYTE ACTIVATION;

EID: 0031814516     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.1.188     Document Type: Article

References (50)

1. Angoli A, Manfredi M, Mossuto L, Piccinelli A. Rapport entre les rythmes héméronyctaux de la tension artérielle et sa pathogénie de l'insuffisance vasculaire cérébrale. Rev Neurol (Paris) 1975;131:597-606.
2. Koskenvuo M, Kaprio J, Telakivi T, Partinen M, Heikkilä K, Sarna S. Snoring as a risk factor for ischaemic heart disease and stroke in men. BMJ 1987;294:16-19.
3. Guilleminault C, Conolly S, Winkle R. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnoea syndrome. Am J Cardiol 1983;52:490-494.
4. McGinty D, Beahm E, Stern N, Littner M, Sowers J, Reige W. Nocturnal hypotension in older men with sleep-related breathing disorders. Chest 1988;94:305-311.
5. Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and hypertension. A population based study. Ann Intern Med 1994;120:382-388.
6. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991;84:613-617.
7. Hamm CW, Lorenz RL, Bleifeld W, Kupper W, Wober W, Weber PC. Biochemical evidence of platelet activation in patients with unstable angina. J Am Coll Cardiol 1987;10:998-1006.
8. Ellis SG, Roubin GS, King SB, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988;77:372-379.
9. Shattil SJ, Budzynski A, Scrutton MC. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding and aggregation in whole blood in the absence of other excitatory agonists. Blood 1989;73:150-158.
10. Hjemdahl P. Physiology of the autonomic nervous system as related to cardiovascular function: implications for stress research. In: Byrne DG, Roseman RH, eds. Anxiety and the heart. New York: Hemisphere Publishing, 1990:95-158.
11. Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 1987;10:35-44.
12. Coleman RM. Periodic movements in sleep (nocturnal myoclonus and restless legs syndrome). In: Guilleminault C, ed. Sleeping and waking disorders. Menlo Park, CA: Addison-Wesley, 1982:265-295.
13. Rechtschaffen A, Kales A, eds. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Bethesda, MD: U.S. Department of Health, Education, and Welfare, Public Health Service-National Institutes of Health, National Institute of Neurological Diseases and Blindness, Neurological Information Network, 1968.
14. Moser NJ, Phillips BA, Berry DTR, Harbison L. What is hypopnea, anyway? Chest 1994;105:426-428.
15. Atlas Task Force of the American Sleep Disorders Association. EEG arousals: scoring rules and examples. A preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;16:174-184.
16. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987;70:307-315.
17. Warkentin TE, Powling MJ, Hardisty RM. Measurements of fibrinogen binding to platelets in whole blood by flow cytometry: a micromethod for the detection of platelet activation. Br J Haematol 1990;76:387-394.
18. Hjemdahl P. Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection. Methods Enzymol 1987;142:521-534.
19. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-475.
20. Partinen M, Jamieson A, Guilleminault C. Long term outcome for obstructive sleep apnea syndrome patients: mortality. Chest 1988;94:1200-1204.
21. Hung J, Whitford EG, Parsons RW. Association of sleep apnoea with myocardial infarction in men. Lancet 1990;336: 261-264.
22. Palomaki H, Partinen M, Erkinjuntti T. Snoring, sleep apnea syndrome and stroke. Neurology 1992;42(suppl 6):75-82.
23. Gainer JL. Hypoxia and atherosclerosis: re-evaluation of an old hypothesis. Atherosclerosis 1987;68:263-266.
24. Rangemark C, Hedner JA, Carlson JT, Gleerup G, Winther K. Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. Sleep 1995;18:188-194.
25. Mizumoto Y, Kasuga H, Ako H, Nishikawa K, Narita N, Kita E. Effects of short term hypoxia on blood platelet function tests of normal subjects. Nippon Kyohu Shikkan Gakki Zasshi 1989;27:811-817.
26. Bokinsky G, Miller M, Ault K, Husband P, Mitchel J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 1995;108:625-630.
27. Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore MR. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 1993;103:722-727.
28. 2-adrenoceptor interaction. J Biol Chem 1986;261:5981-5986.
29. Mitler MM, Carskadon MA, Czeisler CA, Dement WC, Dinges DF, Gräber RC. Catastrophes, sleep and public policy: consensus report. Sleep 1988;11:100-109.
30. Elikowski W, Zozulinska M, Psuja P, Turowiecka Z, Przybyl L, Zawilska K. Platelet activation in young men after myocardial infarction: its relation to metabolic coronary risk factors. Kardiol Pol 1992;36:341-346.
31. Winther K, Hillegass W, Tofler GH, et al. Effects on platelet aggregation and fibrinolytic activity during upright posture and exercise in healthy men. Am J Cardiol 1992;70:1051-1055.
32. Somers VK, Abboud MF. Chemoreflexes-responses, interactions and implications for sleep apnea. Sleep 1993;16:30-34.
33. Jovicic A, Mandic S. Circadian variations of platelet aggregability and fibrinolytic activity in healthy subjects. Thromb Res 1991;62:65-74.
34. Pechan J, Mikulecky M, Okrucka A. Circadian rhythm of beta-thomboglobulin in healthy human subjects. Blood Coagul Fibrinolysis 1992;3:105-107.
35. Michelson AD, Ellis PA, Barnard MR, Matic GB, Viles AF, Kestin AS. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate, or in vivo wound. Blood 1991;77:770-779.
36. Metzelaar MJ, Korteweg J, Sixma JJ, Nieuwenhuis HK. A comparative study on the use of platelet membrane markers for the detection of platelet activation in vitro and in clinical disorders. Thromb Haemost 1991;65:680. Abstract.
37. Brezinski DA, Tofler GH, Muller JE, et al. Morning increase in platelet aggregability. Association with assumption of the upright posture. Circulation 1988;78:35-40.
38. Lande K, Gjesdal K, Fönstelien E, Kjeldsen SE, Eide I. Effects of adrenaline infusion on platelet number, volume and release reaction. Thromb Haemost 1985;54:450-453.
39. Lande K, Kjeldsen SE, Os I, et al. Increased platelet and vascular smooth reactivity to low-dose adrenaline infusion in mild essential hypertension. J Hypertens 1988;6:219-225.
40. Hornyak M, Cejnar M, Elam M, Matousek M, Wallin BG. Sympathetic muscle nerve activity during sleep in man. Brain 1991;114:1281-1295.
41. Wedzicha JA, Syndercombe-Court D, Tan KC. Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxemia. Thorax 1991;46:504-507.
42. Carlson JT, Hedner JA, Ejnell H, Peterson LE. High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 1994;150:72-77.
43. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. Am J Med 1995;98:118-128.
44. Tilkian AG, Guilleminault C, Schroeder JS, Lehrman KL, Simmons FB, Dement WC. Hemodynamics in sleep induced apnea. Studies during wakefulness and sleep. Am Intern Med 1976;85:714-719.
45. Lugaresi E, Coccagna F, Cirignotta F, et al. Breathing during sleep in man in normal and pathological conditions. Adv Exp Med Biol 1978;99:35-45.
46. Maly J, Pecka M, Pinterova E, et al. Changes in platelet function in patients with arterial hypertension. Vnitr Lek 1995;41:458-461.
47. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med 1976;27:465-484.
48. Joern AT, Shurley JT, Brooks RE, Guenter CA, Pierce CM. Short-term changes in sleep patterns on arrival at the South Polar Plateau. Arch Intern Med 1970;125:649-654.
49. Atlas Task Force of the American Sleep Disorders Association. Recording and scoring leg movements. Sleep 1993;16:749-759.
50. Mosko SS, Dickel MJ, Ashurst J. Night-to-night variability in sleep apnea and sleep related periodic leg movements in the elderly. Sleep 1988;11:340-348.